Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2. - sprookjes - yvandenbroek - TriplyDB

Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2.

Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2.

http://www.wikidata.org/entity/Q34120070

about

Shake, rattle, and roll: Impact of the dynamics of flavivirus particles on their interactions with the host Possible future monoclonal antibody (mAb)-based therapy against arbovirus infections An in-depth analysis of original antigenic sin in dengue virus infection Rapid isolation of dengue-neutralizing antibodies from single cell-sorted human antigen-specific memory B-cell cultures Dengue viruses - an overview Precisely Molded Nanoparticle Displaying DENV-E Proteins Induces Robust Serotype-Specific Neutralizing Antibody Responses Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity Structural Basis of Differential Neutralization of DENV-1 Genotypes by an Antibody that Recognizes a Cryptic Epitope Structure of the St. Louis Encephalitis Virus Postfusion Envelope Trimer Structural insights into the neutralization mechanism of a higher primate antibody against dengue virus Structural Analysis of a Dengue Cross-Reactive Antibody Complexed with Envelope Domain III Reveals the Molecular Basis of Cross-Reactivity The structural basis for serotype-specific neutralization of dengue virus by a human antibody An analogue of the antibiotic teicoplanin prevents flavivirus entry in vitro Recombinant Dengue Virus 4 Envelope Glycoprotein Virus-Like Particles Derived from Pichia pastoris are Capable of Eliciting Homotypic Domain III-Directed Neutralizing Antibodies.Defining New Therapeutics Using a More Immunocompetent Mouse Model of Antibody-Enhanced Dengue Virus Infection.A human inferred germline antibody binds to an immunodominant epitope and neutralizes Zika virus.Identification of a conserved JEV serocomplex B-cell epitope by screening a phage-display peptide library with a mAb generated against West Nile virus capsid protein Endemic dengue associated with the co-circulation of multiple viral lineages and localized density-dependent transmission In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection.Identification of two linear B-cell epitopes from West Nile virus NS1 by screening a phage-displayed random peptide library A dynamic landscape for antibody binding modulates antibody-mediated neutralization of West Nile virus Dengue serotype cross-reactive, anti-e protein antibodies confound specific immune memory for 1 year after infection.Analysis of epitopes on dengue virus envelope protein recognized by monoclonal antibodies and polyclonal human sera by a high throughput assay Antibodies against the envelope glycoprotein promote infectivity of immature dengue virus serotype 2 Phage display approaches for the isolation of monoclonal antibodies against dengue virus envelope domain III from human and mouse derived libraries.Innate immunity to dengue virus infection and subversion of antiviral responses.Development of a humanized antibody with high therapeutic potential against dengue virus type 2 Virus-like particle secretion and genotype-dependent immunogenicity of dengue virus serotype 2 DNA vaccine Mechanistic study of broadly neutralizing human monoclonal antibodies against dengue virus that target the fusion loop.The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein Identification of a conserved B-cell epitope on reticuloendotheliosis virus envelope protein by screening a phage-displayed random peptide library Therapeutic efficacy of antibodies lacking Fcγ receptor binding against lethal dengue virus infection is due to neutralizing potency and blocking of enhancing antibodies [corrected].Highly efficient selection of epitope specific antibody through competitive yeast display library sorting Dissection of antibody specificities induced by yellow fever vaccination Antibody-mediated neutralization of flaviviruses: a reductionist view.Analysis of cross-reactive antibodies recognizing the fusion loop of envelope protein and correlation with neutralizing antibody titers in Nicaraguan dengue cases.Human monoclonal single-chain antibodies specific to dengue virus envelope protein.Antigenic analysis of monoclonal antibodies against different epitopes of σB protein of avian reovirus.The type-specific neutralizing antibody response elicited by a dengue vaccine candidate is focused on two amino acids of the envelope protein.A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins

P2860

Q23925011-536CB3D5-BD99-4460-964D-0F79B3BBE1B5 Q24289014-EE436E64-5F2E-44B9-B078-0C8163862456 Q24606493-E02EB8D3-E4D3-4944-9710-A7FD3C50AA88 Q26700070-72305A6B-9E38-4F42-9054-BB146C355E32 Q27026302-6C834C42-8BAA-4B1C-8A9B-9184513F13D7 Q27493140-66741178-1E55-4CB0-8250-EA7C1A06997A Q27654848-D6CB7639-B375-4002-BFFF-2997321E4536 Q27674417-269C521B-CA76-497B-8C05-354457BB5CED Q27674868-D171F297-F11E-42ED-90F1-E7F1A40A5CDC Q27675965-2EB15050-68F6-4F8D-AE85-B2EB12FBC1C6 Q27678419-ADD6E213-5BF0-463F-912F-4328BF04874A Q27681306-3598EB50-2569-459D-BA6B-4BCC23B543CA Q28483817-D67D204F-6902-4A57-8162-E72B3DA7AABA Q30395028-3347F2BA-B0C4-4C7E-8D5C-328588EA43CE Q33425879-CD34F85F-BB5B-4A2D-A2AB-A0A58DF20F0F Q33825684-660F03C3-CD8B-46E6-97D2-5E47D9682FEF Q33837481-15D03584-07E9-495B-AC64-EB37F2C57016 Q33926902-85586F22-11F3-43EA-9A52-514CFB70A133 Q33945441-840ACD7A-EA0E-4FA3-BC61-DEBA9C87F1A2 Q33951093-F73CD8EA-DB3E-40AC-82F8-2861829649D1 Q33954392-72F33BFB-DF5A-426E-9F36-FE0FB72D9F2E Q34042859-39BDBEEC-95EC-4094-BFD2-4ADB9DDF6122 Q34123956-318D8A56-679D-49A9-9F74-6C0BB4C51805 Q34202698-521E59F4-F8E3-4D94-B762-0F2112045645 Q34226542-33FEADCB-3243-495D-87FB-300C7A07A1F9 Q34240105-6CC59567-1DA9-43DF-9DEB-615FCD897593 Q34260219-DAAD88D7-D3FC-4081-84B2-B7A38BD40D7C Q34262245-4F269D59-22A2-4F26-836E-EFEEC33C98B3 Q34306877-1326BDE9-414B-486B-8735-145B3D6033AA Q34386384-55C41548-BB19-4D43-8299-67AE5D8139EA Q34490558-602EF349-B6F1-4EDB-9EB8-A14863A43A94 Q34607919-D0DC75DC-067D-4C4C-BD2D-7182989943BA Q34772027-955D758A-EB4A-4A59-99CA-9A4BF4F721BE Q34789343-94EA6AC2-C57B-4287-844E-94750D1876CD Q34999617-271890B3-70FE-4FBE-B4AC-8ACEE7342B06 Q34999885-8224500E-DE3F-4B61-AD8C-620DA104006B Q35050826-14BE6A3D-8AB2-4C72-A182-3873BC4D371D Q35060573-77B5ADDA-6929-4475-B6F4-319D7F643E3A Q35069160-FB9BCC82-A1F9-477A-A4DC-9F3D334C65A3 Q35138111-B26DBBBE-D1D5-49C6-947F-7F565753972B

P2860

Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2.

http://www.wikidata.org/entity/Q34120070

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Structure and function analysi ...... s against dengue virus type 2.

@ast

Structure and function analysi ...... s against dengue virus type 2.

@en

Structure and function analysi ...... s against dengue virus type 2.

@nl

type

label

Structure and function analysi ...... s against dengue virus type 2.

@ast

Structure and function analysi ...... s against dengue virus type 2.

@en

Structure and function analysi ...... s against dengue virus type 2.

@nl

prefLabel

Structure and function analysi ...... s against dengue virus type 2.

@ast

Structure and function analysi ...... s against dengue virus type 2.

@en

Structure and function analysi ...... s against dengue virus type 2.

@nl

P1433

Q34120070-DA816F8D-183D-4764-9C64-5B2A591454AA

P1476

Q34120070-8D96C18E-E916-48D6-8F8A-60443F264914

P2093

Q34120070-0B4D566E-8B24-4A1D-B6F3-F54762CA530B

Q34120070-5B4E1099-C8AC-4DD2-8054-4F8CADE682A1

Q34120070-78800AF1-8F1C-4F4D-A44F-ECDC9E23DCED

Q34120070-7B0A0BE7-D7D8-4F03-AA06-76C4B74DF412

Q34120070-98C525A6-2281-438B-9D96-0DD92C0E5D57

Q34120070-AE9229A8-C363-4708-B943-7674DEFC809F

Q34120070-E68F09C8-9F13-43E8-A6D7-E8E320A18756

P2860

Q34120070-029FFD95-CF00-4C5C-BA6B-0DCDED783536

Q34120070-06DDCCA1-2BB5-4E87-B705-9C87C10AAA8D

Q34120070-0DDF994D-6442-49B4-9395-280C116227FF

Q34120070-0E0220B6-380D-434C-A030-49334EAD765E

Q34120070-10A69955-B328-4F56-AEA8-CDDADB6DA078

Q34120070-171BAAE4-4338-4B2F-89A0-7E5805D7D2BE

Q34120070-199A507D-B7F6-4E4D-B71A-2FCA09A7286B

Q34120070-19DC4FF9-CD5D-4D78-A0EB-2FC908E3CD21

Q34120070-1C5D09F6-EEF7-4D03-B74E-37DFE3E6AECA

Q34120070-1D417177-C8AD-4289-A2CD-E9505856E690

P304

Q34120070-4881F5E2-F4A9-41DD-A78C-C516FF1A0B9A

P31

Q34120070-2EA1CD77-4EDB-417A-A344-302148B56963

P356

Q34120070-192F0485-3953-4AEE-9768-58E4D75982E2

P407

Q34120070-E4923E8D-56AE-4E29-B208-CDBE38CA8C3C

P433

Q34120070-C7280F7D-AD3E-4DCB-9E7C-A01BBEA0B34D

P478

Q34120070-7FA71440-8697-4CB3-9D2F-19A6E371D8C6

P50

Q34120070-2422C4B4-20E7-4773-A6B8-3E5EA35C061F

Q34120070-27192C13-8E9D-4F31-8925-DECF32646B72

Q34120070-63ECE380-582B-41E4-9454-9C608458D3B8

Q34120070-C5C55A35-8DD0-4329-9B39-7C5535A802FA

Q34120070-DC17A201-1B80-4BB8-90AB-AEAE58D6833E

P5008

Q34120070-41A1BE29-6614-4C6D-8DE9-CD8881A6AE1A

P577

Q34120070-7597FF14-14F4-4CE7-9DFF-184C5B6C2D44

P698

Q34120070-C7568372-31BB-4785-80A1-7136CC4236DB

P921

Q34120070-5B438863-54F5-474D-B568-12080FDE88D8

Q34120070-6BB47197-DEEB-431C-BD36-6DF0380B9CA8

P932

Q34120070-12DB0005-D48C-42E5-AA18-A9CFBA049D95

P356

P1433

Journal of Virology

P1476

Structure and function analysi ...... s against dengue virus type 2.

@en

P2093

Daved H Fremont

http://www.w3.org/2001/XMLSchema#string

James D Brien

http://www.w3.org/2001/XMLSchema#string

Katherine L Williams

http://www.w3.org/2001/XMLSchema#string

Michael Engle

http://www.w3.org/2001/XMLSchema#string

Rebeca Rico-Hesse

http://www.w3.org/2001/XMLSchema#string

S Kyle Austin

http://www.w3.org/2001/XMLSchema#string

Syd Johnson

http://www.w3.org/2001/XMLSchema#string

P2860

Localization and Characterization of Flavivirus Envelope Glycoprotein Cross-Reactive Epitopes

Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses

DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells

Structure of dengue virus: implications for flavivirus organization, maturation, and fusion

Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification

New mouse model for dengue virus vaccine testing

Dengue virus structural differences that correlate with pathogenesis.

Biophysical Characterization and Vector-Specific Antagonist Activity of Domain III of the Tick-Borne Flavivirus Envelope Protein

Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein.

B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus.

P304

9227-9239

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.01087-10

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

84

http://www.w3.org/2001/XMLSchema#string

P50

Michael S. Diamond

Soila Sukupolvi-Petty

Theodore C Pierson

Kimberly A Dowd

P5008

P577

2010-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20592088

http://www.w3.org/2001/XMLSchema#string

P921

P932

2937608

http://www.w3.org/2001/XMLSchema#string